Plasma Vitamin C, but Not Vitamin E, Is Associated With Reduced Risk of Heart Failure in Older MenClinical Perspective by Sasiwarang Goya Wannamethee,

Slides:



Advertisements
Similar presentations
Description of Each Study in the Cross Trial Safety Analysis Solomon SD, et al. Circulation 2008 [Epub Mar 31]
Advertisements

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnoses and Timing of 30-Day Readmissions After.
Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Prognostic Value of N-Terminal Pro–B-Type Natriuretic.
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Randomized Trial of Estrogen Plus Progestin for Secondary.
Geriatric Inpatient Units in the Care of Hospitalized Frail Adults with a History of Heart Failure  Shahyar Michael Gharacholou, Richard Sloane, Harvey.
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
The obesity paradox in men with coronary heart disease and heart failure: The role of muscle mass and leptin  S. Goya Wannamethee, A. Gerald Shaper, Peter.
Copyright © 2006 American Medical Association. All rights reserved.
Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.
Copyright © 2007 American Medical Association. All rights reserved.
Circ Cardiovasc Interv
by Adam J. Singer, Robert H
Circ Cardiovasc Interv
Forecasting the Impact of Heart Failure in the United States
Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,
B-Type Natriuretic Peptide Testing and the Accuracy of Heart Failure Diagnosis in the Emergency DepartmentCLINICAL PERSPECTIVE by Amaali Lokuge, Louisa.
Atrial Fibrillation and Mortality in Heart FailureClinical Perspective
Arterioscler Thromb Vasc Biol
Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.
Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,
by Kiran Musunuru, and Sekar Kathiresan
Sex-Related Differences in Fractional Flow Reserve–Guided Treatment
Peak C-Reactive Protein Level Predicts Long-Term Outcomes in Type B Acute Aortic Dissection by Kenichi Sakakura, Norifumi Kubo, Junya Ako, Hiroshi Wada,
Association Between Mycoplasma Pneumonia and Increased Risk of Ischemic Stroke by Chia-Hung Chiang, Chin-Chou Huang, Wan-Leong Chan, Yu-Chun Chen, Tzeng-Ji.
Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.
Site Selection and Performance in Clinical Trials
Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure PatientsClinical Perspective by Ann M. Swank, John Horton,
Physician and Patient Influences on Provider Performance
Plasma Free Fatty Acids and Risk of Heart FailureClinical Perspective
Risk Factors for Rehospitalization for Acute Coronary Syndromes and Unplanned Revascularization Following Acute Myocardial Infarction by Suzanne V. Arnold,
Circ Cardiovasc Interv
Relative Distributions
Circ Cardiovasc Qual Outcomes
Contribution of Stroke to the Cochrane Stroke Group Trials Register
Effect of Provider Volume on the Accuracy of Hospital Report Cards
by Beverly G. Windham, Michael E
Circ Cardiovasc Qual Outcomes
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,
by Parag C. Patel, Colby R. Ayers, Sabina A
Risk of Heart Failure Among Postmenopausal WomenCLINICAL PERSPECTIVE
Arterial Stiffness, Central Pressures, and Incident Hospitalized Heart Failure in the Chronic Renal Insufficiency Cohort StudyCLINICAL PERSPECTIVE by Julio.
Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic DysfunctionClinical Perspective.
Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,
Resting Ventricular–Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE by Selma F. Mohammed,
Circ Cardiovasc Interv
Cancer in Young Adults With Ischemic Stroke
Harvey B. Simon, MD  The American Journal of Medicine 
International Journal of Cardiology
On Statin Treatment to Prevent Sepsis in Dialysis Patients
The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation  David.
Baseline Characteristics According to Sex
Volume 371, Issue 9628, Pages (June 2008)
Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction 
Kaplan-Meier survival curves for the development of diabetes by quartiles of baseline pedometer steps. Kaplan-Meier survival curves for the development.
Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits?  Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,
EMPA-REG OUTCOME: Cumulative incidence of the primary outcome
Associations between type of MI and incident HF
Lifetime heart failure risk*
Kaplan-Meier curves for the end point all-cause mortality in the total patient population stratified according to complete/incomplete revascularisation.
Cardiac death, target vessel myocardial infarction (MI), target lesion revascularisation (TLR) by Kaplan-Meier method. Cardiac death, target vessel myocardial.
A: Incidences of all-cause mortality, coronary artery events, and cerebrovascular events by quartiles of baPWV during the follow-up period. A: Incidences.
William S. Jenkins, MB, BCh, Véronique L. Roger, MD, MPH, Allan S
Performance of the Manchester Acute Coronary Syndromes decision rule in the validation study. Performance of the Manchester Acute Coronary Syndromes decision.
Adjusted cumulative incidence of stroke, by sex and heart failure status. Adjusted cumulative incidence of stroke, by sex and heart failure status. The.
Proportions of the social isolation—AMI and stroke excess risk mediated by biological, behavioural, socioeconomic and health-related factors. Proportions.
Adjusted cumulative disability incidence by sex and heart failure status. Adjusted cumulative disability incidence by sex and heart failure status. The.
Presentation transcript:

Plasma Vitamin C, but Not Vitamin E, Is Associated With Reduced Risk of Heart Failure in Older MenClinical Perspective by Sasiwarang Goya Wannamethee, Karl Richard Bruckdorfer, Andrew Gerald Shaper, Olia Papacosta, Lucy Lennon, and Peter H. Whincup Circ Heart Fail Volume 6(4):647-654 July 16, 2013 Copyright © American Heart Association, Inc. All rights reserved.

Kaplan–Meier curves of cumulative heart failure (HF) incidence by quartiles of vitamin C in men without and with preexisting myocardial infarction (MI). Kaplan–Meier curves of cumulative heart failure (HF) incidence by quartiles of vitamin C in men without and with preexisting myocardial infarction (MI). Log-rank test: men without MI, P=0.0006; men with MI, P=0.03. Plasma vitamin C, but not vitamin E, is associated with reduced risk of HF in older men. Sasiwarang Goya Wannamethee et al. Circ Heart Fail. 2013;6:647-654 Copyright © American Heart Association, Inc. All rights reserved.